Consistent (1.8–7.2-fold) treatment-induced upregulation of SFRP1 was seen in HCT15, HCT116, and HEC59 analogous to LS-associated CRC and endometrial cancer. This evidence concerns the gene SFRP1 and endometrial cancer.